Additionally, IL-9 levels were found to be higher in peripheral blood mononuclear cells (PBMCs) from CLL patients than in controls and the levels correlated with β2 microglobulin expression and immunoglobulin heavy variable group (IgVH) status. This evidence concerns the gene IL9 and B-cell chronic lymphocytic leukemia.